ARTICLES BY GUNJAN BAGLA
-
![India CROs and CDMOs_Bagla_450x300]( "India's CROs & CDMOs Come Of Age In The Global Marketplace")
India's CROs & CDMOs Come Of Age In The Global Marketplace7/3/2023While a low price is the initial attraction for many American and European companies looking at India’s life sciences ecosystem, there are many additional factors that can be more meaningful.
-
![Medtech Innovations For Diagnostics In India]( "Pandemic Prompts Supply Chain Exodus From China — What's Best For Your Business?")
Pandemic Prompts Supply Chain Exodus From China — What's Best For Your Business?4/27/2020Decisions made in panic rarely work out for the best. In lieu of abandoning operations in China completely, consider these alternatives to secure your company’s supply chain.
Gunjan Bagla
Based in Los Angeles, Gunjan Bagla is managing director of Amritt Inc., a California-based consulting firm focused on helping American companies to succeed in India. His clients include Covidien, Roche Diagnostics, BD, Nordic Naturals, Johnson & Johnson, Gojo, and many more. Gunjan spoke three times at the MD&M West Conference in Anaheim, and was on the keynote panels at MEDevice San Diego and IMDI in Ahmedabad, India. For his India expertise, he has appeared in The New York Times, the Los Angeles Times, and the Washington Post, and on Bloomberg TV, BBC Television, and Fox Business News. He also writes about India for the Harvard Business Review and the Huffington Post. Gunjan has an MBA from Southern Illinois University and a mechanical engineering degree from the Indian Institute of Technology (IIT) Kanpur in India.